Neuromed IRCCS
87
13
15
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.9%
6 terminated/withdrawn out of 87 trials
78.6%
-7.9% vs industry average
2%
2 trials in Phase 3/4
9%
2 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (87)
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
Role: lead
Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
Role: collaborator
Remote Monitoring to Prevent Frailty Progression in the Elderly
Role: lead
Mediterranean Diet on Pregnancy and Foetus Development
Role: lead
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
Role: collaborator
Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.
Role: lead
Transcranial Static Magnetic Stimulation (tSMS) in Huntington's Disease (HD)
Role: lead
Exercise Therapy in Multiple Sclerosis
Role: collaborator
Italian Digital Primary Cardiovascular Prevention Study
Role: collaborator
Effect of Anodal Transcranial Direct Current Stimulation on Postdural Puncture Headache
Role: lead
Transcranial Static Field Stimulation (tSMS) and Transcranial Direct Current Stimulation (tDCS) for the Treatment of Neurological Symptoms.
Role: lead
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
Role: lead
Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation
Role: lead
Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
Role: lead
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)
Role: collaborator
miR-142-3p as Potential Biomarker of Synaptopathy in MS
Role: lead
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
Role: lead
Integrated Treatment in FND (Functional Neurological Disorders)
Role: lead
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
Role: lead
Effectiveness of Multimodal Physical Therapy in Migraine
Role: lead